Compare Super Micro Computer Inc (SMCI) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Super Micro Computer Inc vs Twist Bioscience Corp — how do they compare? Super Micro Computer Inc trades at $41.86 (market cap $28.10B), while Twist Bioscience Corp trades at $159.78 (market cap $10.08B). The key difference: Super Micro Computer Inc is far larger — about 2.8× Twist Bioscience Corp's market cap, and Twist Bioscience Corp is trading nearer its 52-week high, Super Micro Computer Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Super Micro Computer Inc for 19 Days and Twist Bioscience Corp for 27 Days on average.
| SMCI | TWST | |
|---|---|---|
Market Cap | $28.10B | $10.08B |
Volume | 38,581,805 | 4,229,037 |
Sector | Technology | Health |
52-Week High | $55.04 | $205.00 |
52-Week Low | $20.53 | $25.45 |
Typical Hold Time | 19 Days | 27 Days |
Enterprise Value | $33.56B | $10.01B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Super Micro Computer (SMCI) trades at $42.77, down 4.85% on the day, with strong fundamental performance including three consecutive quarterly earnings beats and robust revenue growth projections. The stock shows a bullish technical signal with support at $42 and resistance at $44, while maintaining attractive valuation metrics with a P/E of 13.12 and P/S of 0.76. Recent news highlights AI-driven order growth and successful NVIDIA Vera Rubin platform shipments.
SMCI presents a compelling value opportunity with strong AI infrastructure positioning and solid financials, though investors face risks from ongoing DOJ investigation and AI market volatility. Analyst consensus leans cautious with 56% hold ratings despite $42.33 price target near current levels, suggesting balanced risk-reward profile for growth-oriented investors.
TWST trades at $152.05, down 2.31% today, with a mixed technical picture showing bullish overall signals but bearish moving averages. The company reported Q2 2026 EPS of -$0.56, missing expectations, continuing a trend of losses despite revenue growth to $376.57M in 2025. Recent news highlights a partnership with Lilly TuneLab for AI-driven drug discovery, driving investor optimism.
Outlook remains speculative with high valuation multiples (P/S 21.5, P/B 22.62) and persistent losses, but analyst consensus is bullish (73% buy ratings) with a $145.20 price target. Key risks include cash burn, competitive pressures, and reliance on AI-driven growth catalysts for profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Super Micro Computer Inc
Super Micro Computer, Inc., commonly known as Supermicro, is a leading provider of high-performance and high-efficiency server technology and innovation. The company specializes in designing, manufacturing, and selling advanced server, storage, and networking solutions, primarily for data centers, cloud computing, artificial intelligence, and 5G/Edge computing markets. SMCI's modular architecture allows for the rapid delivery of customized and purpose-built solutions, making it a key player in the enterprise computing and specialized AI infrastructure space.
Read more on SMCI →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
